BioSyent Releases Financial Results for Q1 2024
17.05.2024 - MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) - BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q1) ended March 31, 2024. Key highlights include: (CAD)Q1 2024% Change vs.Q1 2023Trailing ...
Venture Exchange International Financial Reporting Standards Biosyent Inc Company Interim Unaudited Condensed Consolidated Financial Unaudited Condensed Consolidated Statements Goods Sold
Source: wallstreet-online.de